/

Companies / Arsenalbio

Arsenalbio

United States

Arsenal Biosciences, Inc. is a cell therapy company that discovers and develops next-generation in vivo T cell therapies to address chronic disease, including cancer and autoimmunity.

Arsenalbio, based in United States, has 7 investors on file, among them ARCH Venture Partners, Hitachi Ventures and Kleiner Perkins. Its site was last checked 12 Nov 2026: site answers.

Investors

7 investors on file
InvestorEvidenceType
ARCH Venture PartnersPortfolio pageVenture capital
Hitachi VenturesPortfolio pageCorporate VC
Kleiner PerkinsPortfolio pageVenture capital
Luma GroupPortfolio pageVenture capital
Osage University PartnersPortfolio pageVenture capital
SoftBank Vision FundPortfolio pageVenture capital
Westlake BioPartnersPortfolio pageVenture capital

A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data

Free account · no card

Get Arsenalbio and its investors as data

Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when ARCH Venture Partners adds a company.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/companies/arsenalbio.com/investors

# also
GET /v1/companies/arsenalbio.com
GET /v1/companies/arsenalbio.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing